Becton Dickinson and Company (BDX)

$147.51 +4.36 (3.05%)
Market Cap 39.44B
Revenue (ttm) 21.84B
Net Income (ttm) 1.68B
EPS (ttm) N/A
PE Ratio 11.11
Forward PE 11.87
Profit Margin 7.68%
Debt to Equity Ratio 0.61
Volume 3,465,300
Avg Vol 2,811,678
Day's Range N/A - N/A
Shares Out 275.54M
Stochastic %K 37%
Beta 0.22
Analysts Sell
Price Target $177.00

Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 201 847 6800
Website: www.bd.com
Address:
1 Becton Drive, Franklin Lakes, United States
OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 7:36 PM
$BDX RSI: 40.38, MACD: -2.8748 Vol: 4.88, MA20: 150.94, MA50: 155.83 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
knowinvest
knowinvest May. 11 at 4:37 AM
$BDX https://finance.yahoo.com/markets/stocks/articles/jim-cramer-becton-dickinson-company-183633038.html
0 · Reply
MarketBeat
MarketBeat May. 9 at 2:08 PM
https://marketbeat.com/a/8644325/ $BDX Becton, Dickinson and Company Q2 Earnings Call Highlights
0 · Reply
william64
william64 May. 8 at 2:20 PM
$BDX good company, but this market doesn't give a kwap.
0 · Reply
DonCorleone77
DonCorleone77 May. 7 at 1:05 PM
$PTON $FUN $TPR $MCD $BDX PRE-MARKET MOVERS: Currently Higher After Earnings: - Datadog (DDOG) up 30.2% - Fortinet (FTNT) up 15.7% - Howmet Aerospace (HWM) up 10.7% - Unity (U) up 8.3% - Warby Parker (WRBY) up 10.1% - Peloton (PTON) up 10.4% - Six Flags (FUN) up 7.2% - Tapestry (TPR) up 3.0% - TripAdvisor (TRIP) up 0.1% Currently Lower After Earnings: - Planet Fitness (PLNT) down 21.5% - Zoetis (ZTS) down 12.8% - Snap (SNAP) down 8.5% - Arm (ARM) down 8.4% - US Foods (USFD) down 6.4% - Coherent (COHR) down 5.1% - Papa John's (PZZA) down 5.5% - Shell (SHEL) down 2.0% - McDonalds (MCD) down 0.1% .
0 · Reply
OpenOutcrier
OpenOutcrier May. 7 at 12:29 PM
$BDX (+2.9% pre) Becton, Dickinson Non-GAAP EPS of $2.90 beats by $0.13, revenue of $4.7B beats by $30M https://ooc.bz/l/101394
0 · Reply
mikesterz7
mikesterz7 May. 7 at 12:24 PM
$BDX 🚨🚨🚨 Becton, Dickinson and Company reported fiscal second-quarter 2026 revenue of $4.7 billion, up 5.2% year over year, driven by mid‑single‑digit growth across most businesses. U.S. revenue rose to $2.9 billion and international revenue to $1.8 billion. From continuing operations, BD posted a GAAP diluted loss per share of $(0.13) versus earnings of $0.55 a year ago, reflecting higher integration, restructuring and other specified charges and the impact of discontinued operations. On an adjusted basis, diluted EPS from continuing operations was $2.90, up from $2.79. BD executed a $2.0 billion accelerated share repurchase program and retired $2.1 billion of debt during the quarter. After completing the spin-off of its Biosciences and Diagnostic Solutions business, BD reaffirmed its full‑year 2026 revenue growth outlook and raised its adjusted diluted EPS guidance to a range of $12.52 to $12.72.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:38 AM
$BDX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.11 down -203.74% YoY • Reported revenue of $4.71B down -10.58% YoY • BDX reaffirms its full-year fiscal 2026 revenue growth guidance for low single-digit (FXN) and raises its full-year adjusted diluted EPS guidance to $12.52 to $12.72.
1 · Reply
DonCorleone77
DonCorleone77 May. 7 at 3:01 AM
$MCD $HWM $DDOG $ZTS $BDX Some notable companies reporting before tomorrow's open, with earnings consensus estimates: - McDonald's (MCD), consensus $2.74 - Howmet Aerospace (HWM), consensus $1.11 - Datadog (DDOG), consensus 51c - Zoetis (ZTS), consensus $1.62 - Becton Dickinson (BDX), consensus $2.77 - Kenvue (KVUE), consensus 26c - Tapestry (TPR), consensus $1.29 - US Foods (USFD), consensus 81c - Unity (U), consensus 24c - Planet Fitness (PLNT), consensus 63c - Warby Parker (WRBY), consensus 11c - Peloton (PTON), consensus 7c - TripAdvisor (TRIP), consensus (7c) - Shell (SHEL), consensus $2.21 - Six Flags (FUN), consensus ($2.74) - Papa John's (PZZA), consensus 37c
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 10:09 PM
$BDX Current Stock Price: $144.68 Contracts to trade: $145.0 BDX May 15 2026 Call Entry: $3.80 Exit: $6.01 ROI: 58% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Latest News on BDX
Becton Dickinson raises annual profit forecast on strength in drug delivery devices

May 7, 2026, 7:57 AM EDT - 5 days ago

Becton Dickinson raises annual profit forecast on strength in drug delivery devices

BD Appoints Vitor Roque Chief Financial Officer

May 7, 2026, 6:31 AM EDT - 6 days ago

BD Appoints Vitor Roque Chief Financial Officer

BD Reports Second Quarter Fiscal 2026 Financial Results

May 7, 2026, 6:30 AM EDT - 6 days ago

BD Reports Second Quarter Fiscal 2026 Financial Results

BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

May 5, 2026, 6:50 AM EDT - 8 days ago

BD and Wellstar Advance Patient Care and Safety with Medication Management Powered by AI

BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

Apr 30, 2026, 6:50 AM EDT - 13 days ago

BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology

Apr 29, 2026, 6:50 AM EDT - 14 days ago

BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology

BD Board Declares Dividend

Apr 28, 2026, 4:15 PM EDT - 14 days ago

BD Board Declares Dividend

BD to Present at Bank of America Securities Health Care Conference

Apr 27, 2026, 4:15 PM EDT - 15 days ago

BD to Present at Bank of America Securities Health Care Conference

BD Earns Industry Top Honors for Transparency, Resiliency and Partnership

Apr 16, 2026, 6:50 AM EDT - 27 days ago

BD Earns Industry Top Honors for Transparency, Resiliency and Partnership

BD to Announce Financial Results for its Second Quarter of Fiscal 2026

Apr 9, 2026, 4:15 PM EDT - 4 weeks ago

BD to Announce Financial Results for its Second Quarter of Fiscal 2026

Rick Byrd to Retire from BD

Apr 9, 2026, 4:05 PM EDT - 4 weeks ago

Rick Byrd to Retire from BD

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

Apr 9, 2026, 6:50 AM EDT - 4 weeks ago

For Women Managing Nighttime Incontinence, Better Sleep and Comfort Start with BD® PureWick® Urine Collection System

BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

Apr 8, 2026, 6:50 AM EDT - 5 weeks ago

BD Delivers Next‑Generation TIPS Innovation to Advance Portal Hypertension Care Across the European Union

When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight

Apr 7, 2026, 6:50 AM EDT - 5 weeks ago

When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight

BD Launches AI-Enabled Medication Dispensing System to the European Market

Apr 1, 2026, 5:00 AM EDT - 6 weeks ago

BD Launches AI-Enabled Medication Dispensing System to the European Market

BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation

Mar 2, 2026, 6:50 AM EST - 2 months ago

BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor™ 1000mL for Wound Irrigation

Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase

Feb 25, 2026, 4:15 PM EST - 2 months ago

Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase

Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap

Feb 25, 2026, 8:00 AM EST - 2 months ago

Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap

BD to Present at Barclays 28th Annual Global Healthcare Conference

Feb 23, 2026, 4:15 PM EST - 2 months ago

BD to Present at Barclays 28th Annual Global Healthcare Conference

BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency

Feb 23, 2026, 6:50 AM EST - 2 months ago

BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency

Lanesha Minnix Named General Counsel for BD

Feb 19, 2026, 4:15 PM EST - 2 months ago

Lanesha Minnix Named General Counsel for BD

Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities

Feb 10, 2026, 1:00 PM EST - 3 months ago

Becton, Dickinson and Company Announces Tender Offers for Outstanding Debt Securities

Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit

Feb 9, 2026, 8:43 AM EST - 3 months ago

Becton Dickinson cuts annual profit forecast to reflect sale of biosciences and diagnostics unit

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

Feb 9, 2026, 8:40 AM EST - 3 months ago

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

WAT

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

Feb 9, 2026, 8:40 AM EST - 3 months ago

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

WAT

BD Reports First Quarter Fiscal 2026 Financial Results

Feb 9, 2026, 6:30 AM EST - 3 months ago

BD Reports First Quarter Fiscal 2026 Financial Results

BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care

Jan 29, 2026, 6:50 AM EST - 3 months ago

BD and Envetec Demonstrate Closed-Loop Recycling Solution for Laboratory Plastics in Health Care

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26

Jan 27, 2026, 4:15 PM EST - 3 months ago

BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $250 Million Repurchase to Date in FY26

BD to Announce Financial Results for its First Quarter of Fiscal 2026

Jan 27, 2026, 9:26 AM EST - 3 months ago

BD to Announce Financial Results for its First Quarter of Fiscal 2026

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

Jan 27, 2026, 9:25 AM EST - 3 months ago

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

WAT

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

Jan 27, 2026, 9:25 AM EST - 3 months ago

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

WAT

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

Jan 23, 2026, 6:50 AM EST - 3 months ago

BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation

BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

Jan 21, 2026, 6:50 AM EST - 4 months ago

BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

Jan 15, 2026, 6:50 AM EST - 4 months ago

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

BD Names Shawn Bevec as Senior Vice President of Investor Relations

Jan 14, 2026, 6:50 AM EST - 4 months ago

BD Names Shawn Bevec as Senior Vice President of Investor Relations

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

Jan 13, 2026, 6:50 AM EST - 4 months ago

BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs

BD To Host Virtual 2026 Annual Meeting of Shareholders

Jan 12, 2026, 4:15 PM EST - 4 months ago

BD To Host Virtual 2026 Annual Meeting of Shareholders

Why The ‘Magnificent 7' Is Out In 2026 And These 3 Dividends Are ‘In'

Jan 7, 2026, 12:00 PM EST - 4 months ago

Why The ‘Magnificent 7' Is Out In 2026 And These 3 Dividends Are ‘In'

MA UNP

BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial

Jan 5, 2026, 6:50 AM EST - 4 months ago

BD Marks Milestone with First Phasix™ Hernia Prevention Case in Greece and Over 85% Enrollment in U.S. PREVENT Trial

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

Dec 18, 2025, 6:50 AM EST - 5 months ago

BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry

The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners

Dec 17, 2025, 2:20 PM EST - 5 months ago

The Magnificent 7 Are So Yesterday. These Are AI's Next Big Winners

BME

BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec

Dec 15, 2025, 4:40 PM EST - 5 months ago

BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec

BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories

Dec 4, 2025, 6:50 AM EST - 5 months ago

BD and ChemoGLO™ Collaborate to Expand Hazardous Drug Contamination Testing for Health Care Facilities and Laboratories

BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

Dec 3, 2025, 6:50 AM EST - 5 months ago

BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety

Nov 24, 2025, 6:50 AM EST - 6 months ago

BD Surgiphor™ Surgical Wound Irrigation System Expands to Europe to Help Hospitals Improve Patient Safety

BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors

Nov 17, 2025, 4:30 PM EST - 6 months ago

BD Appoints Robert Huffines and Jacqueline Wright to Board of Directors

BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification

Nov 17, 2025, 6:50 AM EST - 6 months ago

BD Onclarity™ HPV Assay for BD COR™ and BD Viper™ LT Systems Receive WHO Prequalification

Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH

Nov 13, 2025, 6:50 AM EST - 6 months ago

Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH

BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go

Nov 12, 2025, 6:50 AM EST - 6 months ago

BD Expands PureWick™ Portfolio with First-of-its-Kind Portable Solution to Confidently Manage Urinary Incontinence On the Go

OfficialStocktwitsUser
OfficialStocktwitsUser May. 12 at 7:36 PM
$BDX RSI: 40.38, MACD: -2.8748 Vol: 4.88, MA20: 150.94, MA50: 155.83 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
knowinvest
knowinvest May. 11 at 4:37 AM
$BDX https://finance.yahoo.com/markets/stocks/articles/jim-cramer-becton-dickinson-company-183633038.html
0 · Reply
MarketBeat
MarketBeat May. 9 at 2:08 PM
https://marketbeat.com/a/8644325/ $BDX Becton, Dickinson and Company Q2 Earnings Call Highlights
0 · Reply
william64
william64 May. 8 at 2:20 PM
$BDX good company, but this market doesn't give a kwap.
0 · Reply
DonCorleone77
DonCorleone77 May. 7 at 1:05 PM
$PTON $FUN $TPR $MCD $BDX PRE-MARKET MOVERS: Currently Higher After Earnings: - Datadog (DDOG) up 30.2% - Fortinet (FTNT) up 15.7% - Howmet Aerospace (HWM) up 10.7% - Unity (U) up 8.3% - Warby Parker (WRBY) up 10.1% - Peloton (PTON) up 10.4% - Six Flags (FUN) up 7.2% - Tapestry (TPR) up 3.0% - TripAdvisor (TRIP) up 0.1% Currently Lower After Earnings: - Planet Fitness (PLNT) down 21.5% - Zoetis (ZTS) down 12.8% - Snap (SNAP) down 8.5% - Arm (ARM) down 8.4% - US Foods (USFD) down 6.4% - Coherent (COHR) down 5.1% - Papa John's (PZZA) down 5.5% - Shell (SHEL) down 2.0% - McDonalds (MCD) down 0.1% .
0 · Reply
OpenOutcrier
OpenOutcrier May. 7 at 12:29 PM
$BDX (+2.9% pre) Becton, Dickinson Non-GAAP EPS of $2.90 beats by $0.13, revenue of $4.7B beats by $30M https://ooc.bz/l/101394
0 · Reply
mikesterz7
mikesterz7 May. 7 at 12:24 PM
$BDX 🚨🚨🚨 Becton, Dickinson and Company reported fiscal second-quarter 2026 revenue of $4.7 billion, up 5.2% year over year, driven by mid‑single‑digit growth across most businesses. U.S. revenue rose to $2.9 billion and international revenue to $1.8 billion. From continuing operations, BD posted a GAAP diluted loss per share of $(0.13) versus earnings of $0.55 a year ago, reflecting higher integration, restructuring and other specified charges and the impact of discontinued operations. On an adjusted basis, diluted EPS from continuing operations was $2.90, up from $2.79. BD executed a $2.0 billion accelerated share repurchase program and retired $2.1 billion of debt during the quarter. After completing the spin-off of its Biosciences and Diagnostic Solutions business, BD reaffirmed its full‑year 2026 revenue growth outlook and raised its adjusted diluted EPS guidance to a range of $12.52 to $12.72.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:38 AM
$BDX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.11 down -203.74% YoY • Reported revenue of $4.71B down -10.58% YoY • BDX reaffirms its full-year fiscal 2026 revenue growth guidance for low single-digit (FXN) and raises its full-year adjusted diluted EPS guidance to $12.52 to $12.72.
1 · Reply
DonCorleone77
DonCorleone77 May. 7 at 3:01 AM
$MCD $HWM $DDOG $ZTS $BDX Some notable companies reporting before tomorrow's open, with earnings consensus estimates: - McDonald's (MCD), consensus $2.74 - Howmet Aerospace (HWM), consensus $1.11 - Datadog (DDOG), consensus 51c - Zoetis (ZTS), consensus $1.62 - Becton Dickinson (BDX), consensus $2.77 - Kenvue (KVUE), consensus 26c - Tapestry (TPR), consensus $1.29 - US Foods (USFD), consensus 81c - Unity (U), consensus 24c - Planet Fitness (PLNT), consensus 63c - Warby Parker (WRBY), consensus 11c - Peloton (PTON), consensus 7c - TripAdvisor (TRIP), consensus (7c) - Shell (SHEL), consensus $2.21 - Six Flags (FUN), consensus ($2.74) - Papa John's (PZZA), consensus 37c
0 · Reply
BillionerOfKing
BillionerOfKing May. 6 at 10:09 PM
$BDX Current Stock Price: $144.68 Contracts to trade: $145.0 BDX May 15 2026 Call Entry: $3.80 Exit: $6.01 ROI: 58% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Windee
Windee May. 5 at 2:17 PM
$BAX Down over 80% year to date. Looks like they’ll never recover. CAN’T FLOG A DEAD HORSE! Market share seems to have gone to $BDX $MRK $PFE & $ABT
1 · Reply
CapitalMonk
CapitalMonk May. 4 at 2:50 PM
$BDX Price: $150.00 (+0.46%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.67% RSI: 37.4 | Momentum: Moderate Volume: -89.0% vs avg Volatility: 1.29% Support: $144.51 | Resistance: $159.95 Tools used: https://www.trade-ideas.com Code: INTERSTOCK25
0 · Reply
STOCKPICKERTRADER
STOCKPICKERTRADER Apr. 30 at 4:00 PM
$BSX noticed the double bottoms on both these guys with some buying pressures building $MDT $IHI $DHR $BDX
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 21 at 11:47 PM
$BDX Share Price: $156.74 Contract Selected: Dec 18, 2026 $155 Calls Buy Zone: $27.62 – $34.12 Target Zone: $50.19 – $61.34 Potential Upside: 72% ROI Time to Expiration: 240 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 14 at 3:37 AM
$BDX Share Price: $155.37 Contract Selected: Sep 18, 2026 $155 Calls Buy Zone: $8.50 – $10.50 Target Zone: $13.99 – $17.10 Potential Upside: 55% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TalkMarkets
TalkMarkets Apr. 8 at 6:55 PM
10 Bargain #Dividend #Stocks For Value And Income $BDX $BR $CDW $CI $HRL https://talkmarkets.com/article/10-bargain-dividend-stocks-for-value-and-income-1775673044
0 · Reply
TalkMarkets
TalkMarkets Apr. 7 at 9:13 PM
Top 10 Bear Market #Stocks For Reliable Dividends $ABT $GPC $SYY $PEP $BDX https://talkmarkets.com/article/f2aee3e0-5b47-4ae7-9176-06f875ebbbd8
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 1 at 3:44 PM
$BDX Share Price: $156.49 Contract Selected: Sep 18, 2026 $155 Calls Buy Zone: $25.50 – $31.50 Target Zone: $46.49 – $56.82 Potential Upside: 72% ROI Time to Expiration: 169 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
SparkyReturns
SparkyReturns Mar. 26 at 4:39 PM
$AMGN $BDX $PFE $MRNA $TAK
1 · Reply
SparkyReturns
SparkyReturns Mar. 25 at 2:40 PM
$AMGN I like AMGN and other big biotechs long term, but wanted to alert you of a company reporting ER and pivotal news after close TODAY. Tiny company (ICU) has the first meaningful improvement in treating Acute Kidney Injury in decades. Already being used with children, and adults soon (50x market size). $9 Million MC, with a TAM in the Billions (read that again). 90% margins. Ramping up product which will become Standard of Care for a number of conditions involving hyper-inflammation and sepsis (AKI, Cardiorenal, burn victims, transplant patients, COVID/respiratory). Saves lives of AKI patients and ELIMINATES dialysis dependency. Total addressable market 2B-20B. Zero debt. Ample runway. Pivotal adult AKI study to be completed in 9 months. Being used at Mayo Clinic, Cinci Childrens, UCSF, Dallas Childrens, dozens more hospitals. 6 (SIX!) Breakthrough Device Designations. So, 9M MC for a company that will be worth Billions in a few years. $BDX $PFE $MRNA $TAK
0 · Reply
anachartanalyst
anachartanalyst Mar. 23 at 4:02 PM
$BDX https://anachart.com/wp-content/uploads/ana_temp/1774281700_soc-img.jpg
0 · Reply
STACKD0E
STACKD0E Mar. 23 at 2:55 PM
$BDX 🙃✨
0 · Reply